Shaw PA - Search Results

1

Cancer precursor lesions in the BRCA population at the time of prophylactic salpingo-oophorectomy: Accuracy of assessment and potential surrogate marker for prevention.

Lheureux S, Shaw PA, Karakasis K, Oza AM. Lheureux S, et al. Among authors: shaw pa. Gynecol Oncol. 2015 Aug;138(2):235-7. doi: 10.1016/j.ygyno.2015.06.014. Epub 2015 Jun 10. Gynecol Oncol. 2015. PMID: 26072440 No abstract available.

2

Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.

Brown TJ, Shaw PA, Karp X, Huynh MH, Begley H, Ringuette MJ. Brown TJ, et al. Among authors: shaw pa. Gynecol Oncol. 1999 Oct;75(1):25-33. doi: 10.1006/gyno.1999.5552. Gynecol Oncol. 1999. PMID: 10502421

3

Activation of androgen receptor-associated protein 70 (ARA70) mRNA expression in ovarian cancer.

Shaw PA, Rittenberg PV, Brown TJ. Shaw PA, et al. Gynecol Oncol. 2001 Feb;80(2):132-8. doi: 10.1006/gyno.2000.6068. Gynecol Oncol. 2001. PMID: 11161850

4

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ. Finch A, et al. Gynecol Oncol. 2006 Jan;100(1):58-64. doi: 10.1016/j.ygyno.2005.06.065. Epub 2005 Aug 31. Gynecol Oncol. 2006. PMID: 16137750

5

Incidental MRI detection of BRCA1-related solitary peritoneal carcinoma during breast screening--A case report.

Hill KA, Rosen B, Shaw P, Causer PA, Warner E. Hill KA, et al. Among authors: shaw p. Gynecol Oncol. 2007 Oct;107(1):136-9. doi: 10.1016/j.ygyno.2007.05.037. Epub 2007 Jul 16. Gynecol Oncol. 2007. PMID: 17629551

6

Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary.

May T, Virtanen C, Sharma M, Milea A, Begley H, Rosen B, Murphy KJ, Brown TJ, Shaw PA. May T, et al. Among authors: shaw pa. Gynecol Oncol. 2010 Apr;117(1):9-17. doi: 10.1016/j.ygyno.2010.01.006. Epub 2010 Feb 1. Gynecol Oncol. 2010. PMID: 20117829

7

Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation.

Vicus D, Finch A, Rosen B, Fan I, Bradley L, Cass I, Sun P, Karlan B, McLaughlin J, Narod SA; Hereditary Ovarian Cancer Clinical Study Group. Vicus D, et al. Gynecol Oncol. 2010 Aug 1;118(2):155-9. doi: 10.1016/j.ygyno.2010.03.009. Epub 2010 May 10. Gynecol Oncol. 2010. PMID: 20452659

8

Diagnosis of epithelial ovarian carcinoma prior to neoadjuvant chemotherapy.

Freedman OC, Dodge J, Shaw P, Oza AM, Bernadini M, Klachook S, Murphy KJ, Lo E, Rosen B, Mackay H. Freedman OC, et al. Gynecol Oncol. 2010 Oct;119(1):22-5. doi: 10.1016/j.ygyno.2010.06.002. Epub 2010 Jun 29. Gynecol Oncol. 2010. PMID: 20591472

9

Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers.

Vicus D, Shaw PA, Finch A, Rosen B, Murphy J, Armel S, Sun P, Narod SA. Vicus D, et al. Among authors: shaw pa. Gynecol Oncol. 2010 Sep;118(3):295-8. doi: 10.1016/j.ygyno.2010.05.012. Gynecol Oncol. 2010. PMID: 20722102

10

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.

Zhang S, Royer R, Li S, McLaughlin JR, Rosen B, Risch HA, Fan I, Bradley L, Shaw PA, Narod SA. Zhang S, et al. Among authors: shaw pa. Gynecol Oncol. 2011 May 1;121(2):353-7. doi: 10.1016/j.ygyno.2011.01.020. Epub 2011 Feb 15. Gynecol Oncol. 2011. PMID: 21324516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters